Demographic and clinical data Demographic data, treatment regimens and the outcome of each incident of Trichosporonosis were recorded. Factors previously reported as predisposing factors to Trichosporon infections were also included in the recording form.
Fig-1 Sample Source of Clinical isolates

Molecular identification DNA extraction
Genomic DNA from clinical isolates, reference strains of Trichosporon species and reference strains of Candida species were isolated by the method of Vijayakumar, et al., (2011) [18] . Briefly, 400 μl of lysis buffer (10mM TRIS), (pH -8), 1mM EDTA (pH -8), 3% SDS and 100 mM NaCl) was taken in a 1.5-ml centrifuge tube. A loop full of Trichosporon culture was suspended in the lysis buffer and heated at 100°C in water bath for 1 min. An equal volume of Phenol: Chloroform was added to this suspension and mixed well. It was then centrifuged at 10,000 rpm for 10 min. The aqueous layer was transferred to a fresh centrifuge tube and the step was repeated again by adding chloroform to the supernatant. The DNA was precipitated with cold isopropyl alcohol, centrifuged and washed with 70% ethanol and dried. The pellet was later re-suspended in 30 μl of Tris-EDTA (TE) buffer and stored at -20°C until use.
Trichosporon specific PCR
The first set of primers used were Trichosporongenus specific primers (TRF -5'AGAGCCTACCATGGTATCA 3' TRR-5'TAAGACCCAATAGAGCCCTA3') [19] . They would precisely amplify only Trichosporon species, by aligning with the small subunit (SSU) of ribosomal DNA (rDNA) sequences, since this region is not conserved in other medically important yeasts. The PCR master mix was prepared containing 25μl of PCR mix (Takara, Japan), 1 μl of forward (TRF) and reverse primer each (TRR) (GeNei, Bangalore), 1 μl of template DNA and the volume made up to 50 μl with sterile nuclease-free water.The reaction mixtures were amplified in a thermal cycler (Veriti 96 well, Applied Biosystems, USA), with the following program: 95°C for 7 min, followed by 30 cycles consisting of 95°C for 30s, 54°C for 30s, and 72°C for 30s, with a final extension period at 72°C for 10min [19] . After thermal cycling, 10μlof the amplified product was run on a 1.5% (wt/vol) agarose gel, stained with ethidium bromide, and visualized with UV light. 
Reference strains
Results
Molecular identification
PCR was performed with Trichosporon genus specific primers to double check for accurate identification of the genus [19] . This pair of primer is Trichosporon specific and amplified part of the nucleotide sequences of the rDNA small subunit (18S). DNA bands of approximately 170bp were obtained for all the isolates tested and for Trichosporon reference strains. In addition, there was no amplification of DNA isolated from Candida albicans ATCC 90028 (negative control) [Fig-2] . Therefore, all our strains were confirmed to belong to the genus Trichosporon.
Demographic and Clinical Data Age and sex distribution
In our study, out of the total 72 patients males (48/72 i.e., 66.7%) were more commonly affected than the females (24/72 i.e., 33.3%). Male to female ratio was 2:1. Trichosporon infections were significantly high in elderly age among men in this study i.e., 41-60 years (37.5%) &>60 years (36.1%) age group, whereas Trichosporon infection rates were high among women in reproductive age group(p = 0.23; p value was calculated by chi square test. It was <0.05, which showed significant association between age interval and gender of the patients). The median age of patients in the present study is 53 years (ranging from 1 day to 90 years) . Two of our patients were neonates who had invasive Trichosporonosis, in whom Trichosporonsp grew in blood. 
Risk factors / Co-morbid conditions
All the patients in our study were associated with any one of the underlying comorbid conditions among which the predominant ones were, diabetes mellitus (56.9%), ICU admission (51.4%), renal failure & post-surgery (29.1%) and hypertension (25%). Few of our patients had intense immunosuppressive states like malignancy (9.7%) and post-transplant / prosthetic valve recipients (5.6%).
Other associated co-morbid conditions which require long term hospitalisation were also observed as associated risk factors among our patients like, cardiac failure (8.3%), cerebrovascular accident (6.9%) and acute pa ncreatitis (2.8.%) [Fig-4 ]. Five of our elderly patients (6.9%) were under ventilator support. Majority of the patients (97.2%) had an indwelling intravenous catheter in our study. Out of the 43 urine samples which grew Trichosporonsp in our study, majority of the patients i.e., 36 (83.7%) were catheterised, contributing to its role as a predominant risk factor in our study. Premamalini T., Rajyoganandh S.V., Vijayakumar R., Kindo Anupma Jyoti and Marak Rungmei S.K.
Associated infections
Majority of the patients in our study i.e., 48 (66.7%) of them had one associated infection with bacteria, fungus or virus. In around 21(29.2%) patients, details of the co-infections were not available. Only 9 (12.5%) of the patients did not have any associated co-infection. Bacterial infection was the most frequently associated one occurring in 32(52.8%) of the patients, next to which comes the fungal infection (9 i.e., 12.5%), and then the viral infection (1 i.e., 1.4%) respectively [Fig-5 ].
Fig-4 Distribution of underlying risk factors/ Co-morbid conditions in study group
Fig-5 Other associated infections in study population
Antimicrobial / Drug treatment All the patients in the current study were under antimicrobial treatment, anti-cancer chemotherapy or steroid treatment. The antimicrobial agents most commonly associated with Trichosporon infection were Carbapenems (33.3%) and inhibitor combinations (38.9%). Receipt of antifungal treatment was the next commonly documented risk factor seen in 27(37.5%) of the patients. The other antimicrobial and immuno-suppressive agents recognised as risk factors in the present study are shown in [Fig-6 ].
Fig-6 Underlying antimicrobial / drug treatment in study population
Clinical outcome
Most of the patients (43 i.e., 59.7%) were discharged. Around three patients in our study group had disseminated Trichosporonosis, and they succumbed to infection. In about 26 (36.1%) of the patients, the outcome was not known since they got discharged against medical advice, or did not turn out for follow up.
Discussion
Trichosporon sp has been so far reported as the second most common cause of disseminated yeast infections in humans, next to the genus Candida [20] . They are emerging opportunistic pathogens causing invasive infections in immunocompromised patients [20, 21] . Such infections are usually difficult to diagnose, do not respond to treatment with routinely used antifungal agents and associated with high mortality rates [21, 22] . Trichosporon species may constitute a part of normal flora of human skin and perigenital area, it is possible that this fungus colonised the catheter from the skin flora during catheterisation, and also would probably evolve as invasive trichosporonosis [24] . We had around 7 PCN samples which grew Trichosporon. Studies suggest that positive stone culture and sensitivity collected by nephrolitholotomy are superior predictors of impending urosepsis than bladder urine [25] . Therefore, it is recommended to collect these specimens on a routine basis in patients with renal stones. [7] . These criteria require isolation of Trichosporon species in blood cultures of patients with temporally related clinical signs and symptoms of infection.
In the present study, 5 i.e. 6.9% of the isolates grew Trichosporon in respiratory sample. In another study by Girmenia, et al., 6 out of 52 cases i.e., 11.5% of the isolates grew Trichosporon sp in respiratory sample which is close to the isolation rate in our study [7] . Out of the 4 (5.6%) wound/pus specimens, 3 grew T.asahii and in one T.cutaneum was isolated. This finding was almost similar to another study by Sheng-Yuan Ruan, et al., where out of the 43 clinical Trichosporon isolates 11 were from wound specimens, out of which 4 were T.asahii and one was T.cutaneum [26] . We had one patient in whom peritoneal dialysis fluid grew Trichosporon sp. Peritonitis is one of the most common and serious complications of peritoneal dialysis, and a case of peritoneal infection due to Trichosporon sp. was documented by Khanna, et al., in 1980 [27] . Analysis of the clinical data of patients in our study showed that, Trichosporon infections were more common in males, with the male-to-female ratio of 2:1. This finding is similar to that reported in other studies [13, 21] . In our study the median age group of the patients was 53 years. In another study by Kontoyiannis, et al., the median age group reported was 44 years [13] . Diabetes mellitus was the most common risk factor observed in 56.9% of the patients. In another study by Wei sun, et al., though diabetes was the most common risk factor the percentage reported was little less i.e. 34.7% [28] . This difference may be due to the variations in the prevalence of diabetes mellitus in different geographical regions. High blood sugar level is associated with impaired leucocyte function, and also provides a favourable environment for the growth of the yeasts, including Trichosporon sp. The next most commonly associated risk factor in our study is ICU admission accounting for 51.4% of the total cases. Several documented cases of trichosporonosis in aged and critically ill patients have been linked with ICU patients in different hospitals by previous researchers, similar to the findings of our study [24, 29] . All the associated co Trichosporonosis -An Association with Clinical Factors and Its Outcome sp is a normal colonizer of the skin and mucous membrane, significant host compromise of both anatomic and neutrophilic defences contributes to the establishment of infection. In most of the patients, the source of the invasive organism is their own flora. In the present study, Trichosporon infections in patients are most frequently associated with bacterial infections (52.8%). Patients who are at a risk of developing Trichosporon infections are also vulnerable to systemic bacterial infections, and frequently receive antimicrobial therapy. This can result in imbalance of microbiota and this along with concomitant bacteremia can aggravate the patient's condition, leading to invasive infections in such patients. Hence, bacterial co-infections should be considered seriously and early initiation of prompt treatment is mandatory. Treatment with antimicrobial agents was observed in almost all the patients in the current study, among which treatment with carbapenems (33.3%) and inhibitor combinations (38.9%) were the most commonly recognised risk factors. In another study by Wei sun, et al., treatment with antimicrobials was the most commonly documented risk factor [28] . The broad spectrum antibiotic destroys the bacteria at the pathogenic site of infection and hence the yeast gets a chance to proliferate. This in turn leads to the establishment of yeast infection. Catheterisation was a major risk factor identified in our study group where 83.7% of the patients were catheterised. This finding was similar to the finding of another study by Pradhan, et al., 2017 where 95% of the patients had indwelling catheters which was a major recognised risk factor [30] .
Conclusion
Mucosal colonisation and consequent invasion by Trichosporon species is predominantly due to break in mucosal barriers. Factors like indwelling catheters, mechanical ventilation, prior infections, and use of broad spectrum antibiotic treatment for documented or presumed bacterial infections all contribute to break in the mucosal barrier, thus leading to the establishment of Trichosporon infection. Therefore, invasive Trichosporon infections may occur in immuno-competent individuals suffering from chronic illness or disruption of skin and mucous membranes. 
